NCT03842111 (AI/AN FACES) is a clinical trial in Head Start Participation, sponsored by Mathematica Policy Research, Inc..

Who is sponsoring NCT03842111?

NCT03842111 is sponsored by Mathematica Policy Research, Inc..

What condition does NCT03842111 study?

NCT03842111 studies Head Start Participation.

Is NCT03842111 still recruiting?

NCT03842111 is currently completed. Last updated 8 October 2019.

Last reviewed 2019-10-08 · How we verify

NCT03842111: AI/AN FACES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

American Indian and Alaska Native Head Start Family and Child Experiences Survey

Completed Last updated 8 October 2019

What this trial tests

trial in Head Start Participation in 1,194 participants. Completed in 30 June 2016.

Timeline

1 October 2014

Primary endpoint
30 June 2016

30 June 2016

Quick facts

Lead sponsor	Mathematica Policy Research, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,194
Start date	1 October 2014
Primary completion	30 June 2016
Estimated completion	30 June 2016
Sites	1 location across United States

Conditions studied

Head Start Participation — all drugs for Head Start Participation →

Sponsor

Mathematica Policy Research, Inc.

Who can join

3 and older, any sex, with Head Start Participation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Head Start Family and Child Experiences Survey (FACES) is a major source of information on Head Start programs and the children and families they serve. Since 1997, FACES has conducted studies in a nationally representative sample of Head Start programs, but has historically not included Region XI (programs operated by federally-recognized tribes), whose programs are designed to serve predominantly American Indian and Alaska Native (AI/AN) children and families. The American Indian and Alaska Native Head Start Family and Child Experiences Survey (AI/AN FACES), the first national study of Region XI AI/AN Head Start children and families, is designed to fill this information gap. For more information on FACES, please refer to the ClinicalTrials.gov ID NCT03705377.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mathematica Policy Research, Inc. trials

Trials by the same sponsor.

NCT06694376 — Understanding and Expanding the Reach of Home Visiting (HV-REACH) Project · not yet recruiting
NCT06329778 — Home-Based Child Care Toolkit for Nurturing School-Age Children Study · completed
NCT05730075 — The Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot Study · completed
NCT05258994 — Early Care and Education Leadership Study: Descriptive Study · completed
NCT05146362 — Vermont RETAIN Impact Evaluation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03842111 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mathematica Policy Research, Inc.
Last refreshed: 8 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03842111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing